The landmark 14-Site study on the role of Next-Generation Sequencing in Periprosthetic Joint Infections has been acknowledged by the journal as being one of the ten that "will have the greatest impact on patient care."
Read Press ReleaseEbola detection kits for humans and animals are now possible using ADI antibody or antigen ELISA kits with results in less than 2 hours. Ebola Rapid test cards, similar to pregnancy tests, have also been developed that provide results in 2-10 mins.
Read Press Release"A Plague of Boils" is one individual's short but powerful memoir on his fight to the death with a skin infection caused by ordinary "staph" bacteria - a germ that can literally be found on everyone's skin, all the time.
Read Press ReleaseSemprus BioSciences today announced it has received a $1 million grant from the U.S. Army Telemedicine & Advanced Technology Research Center (TATRC) to develop the world's first orthopedic devices designed to reduce biofilm formation.
Read Press ReleaseGeoVax has decided to expand its preventative HIV/AIDS vaccine development effort in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH) and the HIV Vaccine Trials
Read Press ReleaseNovaBay Pharmaceuticals, Inc., is innovating a new class of drugs, known as Aganocide® compounds, that mimic the body's natural defense against infection. The Aganocides could potentially equal or exceed the utility of antibiotics.
Read Press ReleasePolyMedix, Inc, has received a Phase 2 grant in the amount of $986,000 from the National Institute of Health (NIH) to support the development of defensin mimetic antimicrobial compounds for the treatment of oral candidiasis.
Read Press ReleaseOver 300,000 patients suffering from stroke and multiple sclerosis or spinal cord injuries resulting in quadriplegia or paraplegia use Foley catheters. These patients are at a daily risk for developing catheter-associated urinary tract infections.
Read Press ReleaseGeoVax is developing a vaccine that presents the natural form of HIV envelope proteins to the immune system on virus-like particles with the envelope proteins present in clusters of three, a confirmation known as trimers.
Read Press Release